Table 3 Clinical and biochemical characteristics of study participants according to rs174583 genotypes
| Â | Men | Â | Women | Â | ||||
|---|---|---|---|---|---|---|---|---|
| Â | CC | CT | TT | Pa | CC | CT | TT | Pa |
LDL-C, (mg/dl) | 116.78 (24.67) | 120.63 (30.85) | 114.36 (28.81) | 0.755 | 113.64 (30.80) | 118.61 (35.12) | 133.27 (28.73) | 0.435 |
HDL-C, (mg/dl) | 42.14 (5.35) | 43.62 (7.60) | 40.10 (7.65) | 0.303 | 48.50 (11.03) | 48.90 (7.78) | 42.00 (13.74) | 0.252 |
Cholesterol, (mg/dl) | 184.20 (26.95) | 189.67 (36.44) | 189.90 (32.69) | 0.744 | 182.79 (34.08) | 188.48 (35.55) | 198.50 (34.51) | 0.591 |
TG, (mg/dl) | 111.00 (81.00, 153.00) | 111.00 (88.00, 140.00) | 171.00 (132.50, 247.00) | 0.037 | 80.00 (68.75, 128.00) | 99.50 (73.75, 130.25) | 107.00 (86.75, 152.00) | 0.551 |
AIP | 0.07 (0.23) | 0.06 (0.23) | 0.26 (0.21) | 0.041 | -0.07 (0.28) | -0.06 (0.20) | 0.08 (0.28) | 0.369 |
Glucose, (mg/dl) | 91.00 (85.00, 97.00) | 92.00 (87.00, 97.00) | 96.50 (87.00, 109.25) | 0.633 | 90.00 (86.00, 94.00) | 89.00 (85.00, 97.25) | 93.00 (82.00, 109.50) | 0.836 |
Insulin, U/mL | 11.40 (9.00, 19.30) | 13.20 (8.60, 24.80) | 10.45 (5.58, 13.98) | 0.144 | 17.45 (9.28, 27.25) | 13.15 (8.55, 19.15) | 20.10 (10.75, 42.55) | 0.265 |
HOMA-IR | 2.68 (2.00, 4.79) | 3.22 (1.95, 5.30) | 2.24 (1.09, 3.38) | 0.246 | 3.89 (1.87, 6.25) | 3.02 (1.94, 4.79) | 4.52 (2.45, 10.93) | 0.326 |
QUICKI | 0.33 (0.03) | 0.32 (0.03) | 0.34 (0.03) | 0.285 | 0.33 (0.04) | 0.32 (0.03) | 0.31 (0.04) | 0.426 |
SBP (mmHg) | 114.63 (23.04) | 117.82 (12.45) | 120.00 (14.14) | 0.618 | 112.29 (13.87) | 113.52 (13.32) | 111.83 (7.76) | 0.913 |
DBP (mmHg) | 75.54 (15.88) | 76.41 (11.12) | 76.50 (9.14) | 0.955 | 76.25 (10.40) | 77.14 (12.44) | 71.33 (7.66) | 0.514 |
Mets (%) | 41.2 | 38.2 | 20.6 | 0.303 | 43.8 | 50.0 | 6.2 | 0.478 |